Lung Cancer Therapeutics Market Size, Segmentation, Growth Factor, Demands, Analysis, Regional Forecast to 2026

 The targeted segment is forecast to emerge dominant among various therapies in The Global Lung Cancer Therapeutics Market, finds Fortune Business Insights in a new study. The study is titled “Lung Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026.” According to the study, the global lung cancer therapeutics market will exhibit an exponential CAGR of 13.0% to reach a value of US$ 48,725.9 Mn by 2026 from US$ 18,327.6 Mn in 2018. Lung cancer is considered one of the leading causes of death by cancer. Cancer can be a result of continuous exposure to asbestos, and unhealthy lifestyle that includes habits such as pipe smoking, cigarette smoking, cigar smoking. The rising incidence of lung cancer is subsequently fuelling demand for various therapies in the global lung cancer therapeutics market.

The report covers:

  • Global Lung Cancer Therapeutics Market trends, with detailed analysis on consumer trends & manufacturer trends.
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe.
  • Competitive analysis of the industry players along with the overview on strategic management.
  • Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lung-cancer-therapeutics-market-100473

Leading Players operating in the Lung Cancer Therapeutics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Astellas Pharma US
  • Celgene
  • Merck Sharp & Dohme GmbH
  • Pfizer
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • AstraZeneca
  • Boehringer Ingelheim Pharmaceutical, Takeda
  • Novartis

The Asia Pacific to Emerge as the Fastest Growing Region with Rising in Cancer Awareness Programs

North America is expected to dominate the global market for lung cancer therapeutics. In 2018 the region generated a revenue of US$ 8,093.2 Mn. Growth in this region is attributable to the rising prevalence and diagnostics of lung cancer and the increasing adoption of advanced lung cancer therapeutics. Besides this, increasing awareness about cancer is enabling the market in Asia Pacific exhibit a faster CAGR.

A few novel therapeutics are introduced in the market, impelling leading players to research on improved medication. For instance, Genentech, a company operating in the lung cancer therapeutics market has recently launched their new drug named, Alecensa (alectinib), in order to treat ALK-positive non-small cell lung cancer. Such strategies adopted by players will bode well for the global lung cancer therapeutics market in the long run.

Market Segmentation:

By Therapy

  • Targeted Therapy
  • Bevacizumab
  • Dabrafenib/Trametinib
  • Erlotinib Hydrochloride
  • Osimertinib
  • Others
  • Immunotherapy
  • Durvalumab
  • Nivolumab
  • Atezolizumab
  • Pembrolizumab
  • Chemotherapy

By Cancer Type

  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Lung Cancer Therapeutics Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

Related Reports:

Spirometer Market Size, Share, Statistics, Trends, Competitive analysis, Regional Growth from 2023 to 2029

Arthroscopy Fluid Management Disposables Market Key Drivers, Size, Regional Overview and Top Players and Forecast to 2028

Normal Saline for Parenteral Use Market 2023 | Size, Share, Demands, Growth Analysis, Company Profiles, Revenue and Forecast by 2029

Spirometer Market Size, Share, Statistics, Trends, Competitive analysis, Regional Growth from 2023 to 2029

Normal Saline for Parenteral Use Market Key Drivers, Size, Regional Overview and Top Players and Forecast to 2028

Dental Equipment Market 2023 | Size, Share, Demands, Growth Analysis, Company Profiles, Revenue and Forecast by 2029

Comments

Post a Comment

Popular posts from this blog

Interventional Cardiology Devices Market Size, Share, Growth and Demand

  Interventional Cardiology Devices Market Size, Share & COVID-19 Impact Analysis, By Type (Coronary Vascular Devices and Structural Heart Devices), By Product (Coronary Stents, Heart Valve Therapy Devices, Angioplasty Balloons, Atherectomy Devices, Intravascular Ultrasound (IVUS) Devices, and Others), By End User (Hospitals & Ambulatory Surgical Centers and Clinics & Others), and Regional Forecasts, 2022-2029 The global interventional cardiology devices market size was valued at USD 13.67 billion in 2021. The market is projected to grow from USD 14.61 billion in 2022 to USD 23.61 billion by 2029, exhibiting a CAGR of 7.1% during the forecast period. Prevalence of Cardiovascular Diseases (CVDs) such as coronary heart disease, stroke, and atrial fibrillation to propel the market progression . There is focus on the production and launch of advanced devices to meet the growing demand for minimally invasive devices. Fortune Business Insights ™ shares this information ...
Read more

Nebulizer Market Size, Share and Demand 2023-2030

The Nebulizer Market Size was a significant segment within the healthcare industry. Nebulizers are medical devices used to administer medication in the form of a mist that is inhaled into the lungs. They are commonly used for patients with respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.  Here are some key points related to the Nebulizer Market: Market Growth and Size : The global Nebulizer Market had been experiencing steady growth, driven by factors such as the increasing prevalence of respiratory diseases, advancements in technology, and a growing aging population. Types of Nebulizers : The market includes various types of nebulizers , including jet nebulizers, ultrasonic nebulizers, and mesh nebulizers. Each type operates using different mechanisms to convert liquid medication into a fine mist. Home Use and Hospital Settings : ...
Read more

Legionella Testing Market 2023-2028

The Legionella testing market refers to the industry involved in the detection and analysis of Legionella bacteria in various environments, particularly in water systems. Legionella is a type of bacteria that can cause a severe form of pneumonia known as Legionnaires' disease, and a milder flu-like illness called Pontiac fever. These bacteria can be present in natural water sources like rivers and lakes, but they can also multiply in human-made water systems such as cooling towers, hot tubs, plumbing systems, and other water-containing systems. The Legionella testing market primarily serves healthcare facilities, hotels, cruise ships, industrial facilities, and other locations with water systems that are at risk of Legionella contamination. The market includes various testing methods, such as: Culturing : This method involves collecting water samples and growing Legionella bacteria in a laboratory culture. It's a traditional but time-consuming process. M...
Read more